BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36365148)

  • 1. Epidemiology of Treated Diabetes Ocular Complications in France 2008-2018-The LANDSCAPE French Nationwide Study.
    Creuzot-Garcher C; Massin P; Srour M; Baudin F; Dot C; Nghiem-Buffet S; Girmens JF; Collin C; Ponthieux A; Delcourt C
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and prevalence of diabetic macular edema and proliferative diabetic retinopathy, their progression to visual impairment and patterns in their intravitreal treatment in the Finnish population.
    Heloterä H; Arffman M; Sund R; Keskimäki I; Kaarniranta K
    Acta Ophthalmol; 2024 Mar; ():. PubMed ID: 38523129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis.
    Xie J; Ikram MK; Cotch MF; Klein B; Varma R; Shaw JE; Klein R; Mitchell P; Lamoureux EL; Wong TY
    JAMA Ophthalmol; 2017 Jun; 135(6):586-593. PubMed ID: 28472362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic risk factors contribute differently to the development of proliferative diabetic retinopathy and clinically significant macular oedema.
    Bek T
    Diabetologia; 2020 Nov; 63(11):2462-2470. PubMed ID: 32696115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in diabetic eye disorders and associated comorbidities in Taiwan: a 10-year nationwide population-based cohort study.
    Lin CC; Lee CY; Huang JY; Hsu SM; Hung JH; Yang SF
    Br J Ophthalmol; 2023 Sep; 107(9):1303-1310. PubMed ID: 35396213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severity of diabetic macular edema (DME) in Seine St Denis among patients treated by anti-VEGF].
    Stéphan S; Fajnkuchen F; Addou-Regnard M; Grenet T; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2014 Nov; 37(9):717-21. PubMed ID: 25308789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study.
    Lois N; Cook JA; Wang A; Aldington S; Mistry H; Maredza M; McAuley D; Aslam T; Bailey C; Chong V; Ganchi F; Scanlon P; Sivaprasad S; Steel DH; Styles C; Azuara-Blanco A; Prior L; Waugh N;
    Ophthalmology; 2021 Apr; 128(4):561-573. PubMed ID: 33130144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Prevalence of Neovascular Age-Related Macular Degeneration in France between 2008 and 2018: The LANDSCAPE Study.
    Creuzot-Garcher CP; Srour M; Baudin F; Daien V; Dot C; Nghiem-Buffet S; Girmens JF; Coulombel N; Ponthieux A; Delcourt C
    Ophthalmol Sci; 2022 Mar; 2(1):100114. PubMed ID: 36246186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Trends in the Treatment of Proliferative Diabetic Retinopathy: An AAO IRIS® Registry Analysis.
    Gong D; Hall N; Elze T; Sobrin L; Miller JW; Lorch A; Miller JB;
    Ophthalmol Sci; 2021 Sep; 1(3):100037. PubMed ID: 36247812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of morphological characteristics of diabetic macular edema in patients with non-proliferative versus proliferative diabetic retinopathy: a spectral-domain optical coherence tomography study.
    Chatziralli I; Theodossiadis G; Dimitriou E; Theodossiadis P
    Int Ophthalmol; 2021 Jul; 41(7):2417-2424. PubMed ID: 33772414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
    Hutton DW; Stein JD; Glassman AR; Bressler NM; Jampol LM; Sun JK;
    JAMA Ophthalmol; 2019 Dec; 137(12):1424-1432. PubMed ID: 31647496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy.
    O'Fee JR; Juliano J; Moshfeghi AA
    Graefes Arch Clin Exp Ophthalmol; 2022 Jul; 260(7):2191-2200. PubMed ID: 35192029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
    Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
    JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is immediate treatment necessary for diabetic macular edema after pars plana vitrectomy for tractional complications of proliferative diabetic retinopathy?
    Behera UC; Das T; Sivaprasad S; Rani PK; Raman R; Agarwal M; Agarwal T; Sahu S; Vaidya H; Panchal B;
    Int Ophthalmol; 2021 Nov; 41(11):3607-3614. PubMed ID: 34170479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.
    Stewart MW
    Ophthalmol Ther; 2017 Jun; 6(1):33-47. PubMed ID: 28324452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteome Changes Associated with the VEGFR Pathway and Immune System in Diabetic Macular Edema Patients at Different Diabetic Retinopathy Stages.
    Han R; Gong R; Liu W; Xu G
    Curr Eye Res; 2022 Jul; 47(7):1050-1060. PubMed ID: 35435079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema.
    Hernández C; Fonollosa A; García-Ramírez M; Higuera M; Catalán R; Miralles A; García-Arumí J; Simó R
    Diabetes Care; 2006 Sep; 29(9):2028-33. PubMed ID: 16936148
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.